Skip to main navigation Skip to search Skip to main content

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

  • AMFS Investigators
  • , ATHENS Melanoma Study Group
  • , GenoMEL Consortium
  • , Essen-Heidelberg Investigators
  • , The SDH Study Group
  • , Q-MEGA and QTWIN Investigators
  • Queensland Institute of Medical Research
  • University of Leeds
  • University of Texas MD Anderson Cancer Center
  • Institut national de la santé et de la recherche médicale
  • Université Paris Cité
  • University of Western Australia
  • Tianjin Medical University
  • German Cancer Research Center
  • University of Cambridge
  • Institute of Cancer Research
  • National and Kapodistrian University of Athens
  • University of Bergen
  • University of Oslo
  • Sheba Medical Center at Tel Hashomer
  • University of Genoa
  • University and San Martino Hospital of Genoa
  • National Institutes of Health
  • Pomeranian Medical University in Szczecin
  • University of Pennsylvania
  • University of Paris 13
  • Leiden University
  • Karolinska Institutet
  • Institute of Oncology Ljubljana
  • Lund University
  • Moffitt Cancer Center
  • University of Glasgow
  • McGill University
  • The University of Sydney
  • University of Barcelona
  • Centro de Investigación Biomédica en Red
  • Brown University
  • Royal Brisbane and Women's Hospital
  • University of Queensland
  • Flinders University
  • University of Duisburg-Essen
  • German Consortium for Translational Cancer Research (DKTK)
  • University of Tasmania
  • Queensland University of Technology
  • Indiana University-Purdue University Indianapolis
  • Indiana University Bloomington
  • University of Münster
  • Dartmouth College

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Abstract

Thirteen common susceptibility loci have been reproducibly associated with cutaneous malignant melanoma (CMM). We report the results of an international 2-stage meta-analysis of CMM genome-wide association studies (GWAS). This meta-analysis combines 11 GWAS (5 previously unpublished) and a further three stage 2 data sets, totaling 15,990 CMM cases and 26,409 controls. Five loci not previously associated with CMM risk reached genome-wide significance (P < 5 × 10-8), as did 2 previously reported but unreplicated loci and all 13 established loci. Newly associated SNPs fall within putative melanocyte regulatory elements, and bioinformatic and expression quantitative trait locus (eQTL) data highlight candidate genes in the associated regions, including one involved in telomere biology.

Original languageEnglish
Pages (from-to)987-995
Number of pages9
JournalNature Genetics
Volume47
Issue number9
DOIs
StatePublished - 27 Aug 2015

Funding

FundersFunder number
National Institutes of HealthUL1TR001108
National Cancer InstituteP30CA023108, R01CA133996, R01CA083115, R01CA122838, R03CA167741, R01CA088363, R01CA100264, P50CA093459
National Center for Advancing Translational SciencesUL1TR001108, UL1TR002529
Medical Research CouncilMR/L01629X/1
European Commission294576

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma'. Together they form a unique fingerprint.

    Cite this